약물동태 서비스 시장 : 유형별, 용도별 - 세계 전망(2025-2030년)

The Pharmacokinetics Services Market was valued at USD 1.04 billion in 2023, expected to reach USD 1.11 billion in 2024, and is projected to grow at a CAGR of 7.37%, to USD 1.71 billion by 2030.

Pharmacokinetics services refer to the study of drug absorption, distribution, metabolism, and excretion (ADME) in the human body, essential in drug development to ensure safety, efficacy, and therapeutic effectiveness. The necessity of these services is driven by stringent regulatory requirements, growing drug development activities, and the increasing prevalence of chronic diseases necessitating effective treatments. Pharmacokinetics is applied in various phases of drug development, including early discovery, clinical development, and post-market monitoring, with end-use spanning pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic institutions. The market is highly influenced by a rising demand for personalized medicine, advancements in technology such as high-throughput screening, and a growing focus on biologics and biosimilars. Opportunities lie in the integration of AI and machine learning for predictive analytics in pharmacokinetics, which can streamline drug discovery processes, as well as expanding services in emerging markets where pharmaceutical industries are rapidly growing. However, limitations exist due to the high cost of advanced technologies involved, complexities in understanding complex biological systems, and a stringent regulatory framework that can delay product launches. The evolving landscape presents challenges in terms of maintaining data accuracy and relevance in predictive models. For business growth, innovation could focus on developing cost-effective pharmacokinetic models and simulation tools to enhance drug development efficiency. Additionally, expanding into pharmacogenomics could provide insights into individual variations in drug kinetics, aligning with the trend towards personalized medicine. The market's nature is dynamic and competitive, requiring constant innovation and adaptability to emerging technologies and regulatory standards. Companies must leverage strategic partnerships and invest in R&D to maintain a competitive edge, focusing on emerging areas like biologics, RNA-based therapeutics, and nanomedicine, which are significantly transforming the pharmacokinetics landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmacokinetics Services Market

The Pharmacokinetics Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Demand for personalized medicine that requires personalized pharmacokinetic assessments
  • Increased demand for cost-effective drug development and clinical trial designs
  • Government support for pharmacokinetics research and services
• Market Restraints
  • High costs associated with the development of novel drugs that require pharmacokinetic assessment
• Market Opportunities
  • Implementation of advanced technologies in pharmacokinetics
  • Growing use of predictive analytics to improve efficiency and accuracy of predictions based on PK data
• Market Challenges
  • Stringent regulatory requirements for the approval of drugs and therapies related to pharmacokinetics services

Porter's Five Forces: A Strategic Tool for Navigating the Pharmacokinetics Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmacokinetics Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmacokinetics Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmacokinetics Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmacokinetics Services Market

A detailed market share analysis in the Pharmacokinetics Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmacokinetics Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmacokinetics Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmacokinetics Services Market

A strategic analysis of the Pharmacokinetics Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmacokinetics Services Market, highlighting leading vendors and their innovative profiles. These include Absorption Systems LLC, Allucent, Aurigene Pharmaceutical Services Ltd., Certara, Charles River Laboratories, Inc., Creative Bioarray, Eurofins Scientific SE, Evotec SE, Frontage Laboratories, Inc., ICON PLC, Laboratory Corporation of America Holdings, LGC Limited, NUVISAN Pharma Holding GmbH, Pacific BioLabs, Parexel International (MA) Corporation, Pfizer Inc., PPD Inc. by Thermo Fisher Scientific Inc., Premier Consulting, Reaction Biology Corporation, SGS SA, Svar Life Science AB, WuXi AppTec Co., Ltd., XenoTech, and Xyzagen.

Market Segmentation & Coverage

This research report categorizes the Pharmacokinetics Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Large Molecules Pharmacokinetics Services and Small Molecules Pharmacokinetics Services.
• Based on Application, market is studied across Large Enterprise and Small and Medium Enterprise.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Demand for personalized medicine that requires personalized pharmacokinetic assessments
    • 5.1.1.2. Increased demand for cost-effective drug development and clinical trial designs
    • 5.1.1.3. Government support for pharmacokinetics research and services
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with the development of novel drugs that require pharmacokinetic assessment
  • 5.1.3. Opportunities
    • 5.1.3.1. Implementation of advanced technologies in pharmacokinetics
    • 5.1.3.2. Growing use of predictive analytics to improve efficiency and accuracy of predictions based on PK data
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for the approval of drugs and therapies related to pharmacokinetics services
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmacokinetics Services Market, by Type

• 6.1. Introduction
• 6.2. Large Molecules Pharmacokinetics Services
• 6.3. Small Molecules Pharmacokinetics Services

7. Pharmacokinetics Services Market, by Application

• 7.1. Introduction
• 7.2. Large Enterprise
• 7.3. Small and Medium Enterprise

8. Americas Pharmacokinetics Services Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Pharmacokinetics Services Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Pharmacokinetics Services Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Absorption Systems LLC
• 2. Allucent
• 3. Aurigene Pharmaceutical Services Ltd.
• 4. Certara
• 5. Charles River Laboratories, Inc.
• 6. Creative Bioarray
• 7. Eurofins Scientific SE
• 8. Evotec SE
• 9. Frontage Laboratories, Inc.
• 10. ICON PLC
• 11. Laboratory Corporation of America Holdings
• 12. LGC Limited
• 13. NUVISAN Pharma Holding GmbH
• 14. Pacific BioLabs
• 15. Parexel International (MA) Corporation
• 16. Pfizer Inc.
• 17. PPD Inc. by Thermo Fisher Scientific Inc.
• 18. Premier Consulting
• 19. Reaction Biology Corporation
• 20. SGS SA
• 21. Svar Life Science AB
• 22. WuXi AppTec Co., Ltd.
• 23. XenoTech
• 24. Xyzagen